Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cureus|August 15, 2019
Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After PembrolizumabShashank Sama, Matthew J Hadfield, Nerea Lopetegui Lia, et al.
The Annals of Pharmacotherapy|February 25, 2023
Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor AntagonistsMatthew J Hadfield, Vikram Lyall, Lisa M Holle, et al.
Rhode Island Medical Journal (2013)|January 27, 2026
Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell CarcinomaGrace Sun, Elias O U Eteshola, Matthew J Hadfield, et al.
International Journal of Molecular Sciences|January 11, 2024
Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated ReviewMatthew J Hadfield, Kathryn DeCarli, Kinan Bash, et al.
Cureus|May 29, 2020
A Rare Case of Clear Cell Adenocarcinoma of the Cervix with No Intrauterine Diethylstilbestrol ExposureVinay Mathew Thomas, Swetha Ann Alexander, Matthew J Hadfield, et al.
Best Practice & Research. Clinical Haematology|July 23, 2025
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, et al.
Frontiers in Bioscience (Landmark Edition)|June 11, 2013
Poly(ADP-ribose) polymerase inhibitors as cancer therapyJohn F Hilton, Matthew J Hadfield, Minh-Thu Tran, et al.
American Journal of Clinical Oncology|November 21, 2023
Genomic and Molecular Characteristics of Ovarian CarcinosarcomaKristy Ramphal, Matthew J Hadfield, Christina M Bandera, et al.
Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
Pageof 4